Axid, Axid Ar (nizatidine) is a small molecule pharmaceutical. Nizatidine was first approved as Axid on 1988-04-12. It is used to treat duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. Nizatidine's patent is valid until 2022-07-17 (FDA).
|Trade Name||Axid, Axid Ar|
|Indication||duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, helicobacter infections, peptic esophagitis, stomach ulcer, urticaria, zollinger-ellison syndrome|
|Drug Class||H2-receptor antagonists (cimetidine type)|